Systematic Lymphadenectomy and Oncological Outcomes of Women With Apparent Early-Stage Clear Cell Carcinoma of the Endometrium: A Multi-Institutional Cohort Study

被引:0
作者
Tian, Yong [1 ]
Ran, Lin [1 ]
Liu, Yi [1 ]
Xu, Yu [2 ]
Shen, Juan [3 ]
Mi, Gong-sheng [3 ]
Ke, Feng-mei [1 ]
机构
[1] Wuhan Univ, Enshi Clin Coll, Cent Hosp Enshi Tujia & Miao Autonomous Prefectur, Dept Obstet & Gynecol, Enshi, Peoples R China
[2] Sichuan Univ, West China Second Univ Hosp, Dept Obstet & Gynecol, Chengdu, Peoples R China
[3] Mianyang Cent Hosp, Dept Obstet & Gynecol, Mianyang, Peoples R China
来源
FRONTIERS IN ONCOLOGY | 2022年 / 12卷
关键词
lymphadenectomy; clear cell carcinoma; endometrial cancer; overall survival; disease-free survival; PELVIC LYMPHADENECTOMY; RISK-FACTORS; CANCER; CORPUS; GUIDELINES; MANAGEMENT;
D O I
10.3389/fonc.2022.800957
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
ObjectiveThe survival value of systematic lymphadenectomy for endometrial cancer is ambiguous and controversial. The current study aimed to evaluate the long-term survival role of combined pelvic and para-aortic lymphadenectomy in patients with presumed early-stage clear cell carcinoma of the endometrium. MethodsPatients in three Chinese teaching hospitals who presented between 2012 and 2017 with apparent early-stage clear cell carcinoma of the endometrium and underwent surgical staging were selected. Patients who did and did not undergo systematic lymphadenectomy were identified and clinicopathological characteristics were compared. Disease-free survival and overall survival were evaluated following the generation of the Kaplan-Meier curves and the comparison using the log-rank test. A Cox proportional hazards model was employed to control for confounders. ResultsA total of 244 patients underwent systematic lymphadenectomy and 89 did not receive lymph node dissection. The demographic and baseline data were comparable between the two groups. The rate of disease-free survival at 5 years was 64.10% in patients who underwent systematic lymphadenectomy and 45.05% in patients who did not undergo lymphadenectomy. Patients who underwent systematic lymphadenectomy had better disease-free survival than those who did not receive lymphadenectomy (HR, 0.54. 95% CI, 0.38-0.76. P=0.000). The rate of 5-year overall survival was 68.87% in the lymphadenectomy group and 53.33% in patients who did not undergo systematic lymphadenectomy. Systematic lymphadenectomy was also associated with improved 5-year overall survival for women with presumed early-stage clear cell carcinoma of the endometrium (HR, 0.58. 95% CI, 0.39-0.85. P=0.005). After adjusting for confounders, systematic lymphadenectomy was still independently associated with improved disease-free survival and overall survival. ConclusionPatients with apparent early-stage clear cell carcinoma of the endometrium who underwent systematic lymphadenectomy had better long-term survival than those who did not undergo systematic lymphadenectomy.
引用
收藏
页数:9
相关论文
共 34 条
  • [1] Clear Cell Carcinoma of the Endometrium Evaluation of Prognostic Parameters in a Multi-institutional Cohort of 165 Cases
    Abdulfatah, Eman
    Sakr, Sharif
    Thomas, Sumi
    Al-Wahab, Zaid
    Mutch, David G.
    Dowdy, Sean
    Bandyopadhyay, Sudeshna
    Munkarah, Adnan
    Elshaikh, Mohamed
    Morris, Robert
    Ali-Fehmi, Rouba
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (08) : 1714 - 1721
  • [2] ABELER VM, 1991, GYNECOL ONCOL, V40, P207
  • [3] World Medical Association Declaration of Helsinki Ethical Principles for Medical Research Involving Human Subjects
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2013, 310 (20): : 2191 - 2194
  • [4] Sentinel node mapping vs. lymphadenectomy in endometrial cancer: A systematic review and meta-analysis
    Bogani, Giorgio
    Murgia, Ferdinando
    Ditto, Antonino
    Raspagliesi, Francesco
    [J]. GYNECOLOGIC ONCOLOGY, 2019, 153 (03) : 676 - 683
  • [5] Current recommendations and recent progress in endometrial cancer
    Brooks, Rebecca A.
    Fleming, Gini F.
    Lastra, Ricardo R.
    Lee, Nita K.
    Moroney, John W.
    Son, Christina H.
    Tatebe, Ken
    Veneris, Jennifer L.
    [J]. CA-A CANCER JOURNAL FOR CLINICIANS, 2019, 69 (04) : 258 - 279
  • [6] Therapeutic role of lymph node resection in endometrioid corpus cancer - A study of 12,333 patients
    Chan, John K.
    Cheung, Michael K.
    Huh, Warner K.
    Osann, Kathryn
    Husain, Amreen
    Teng, Nelson N.
    Kapp, Daniel S.
    [J]. CANCER, 2006, 107 (08) : 1823 - 1830
  • [7] UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses
    Chandrashekar, Darshan S.
    Bashel, Bhuwan
    Balasubramanya, Sai Akshaya Hodigere
    Creighton, Chad J.
    Ponce-Rodriguez, Israel
    Chakravarthi, Balabhadrapatruni V. S. K.
    Varambally, Sooryanarayana
    [J]. NEOPLASIA, 2017, 19 (08): : 649 - 658
  • [8] Non-endometrioid carcinomas of the uterine corpus: A review of their pathology with emphasis on recent advances and problematic aspects
    Clement, PB
    Young, RH
    [J]. ADVANCES IN ANATOMIC PATHOLOGY, 2004, 11 (03) : 117 - 142
  • [9] ESGO/ESTRO/ESP guidelines for the management of patients with endometrial carcinoma
    Concin, Nicole
    Matias-Guiu, Xavier
    Vergote, Ignace
    Cibula, David
    Mirza, Mansoor Raza
    Marnitz, Simone
    Ledermann, Jonathan
    Bosse, Tjalling
    Chargari, Cyrus
    Fagotti, Anna
    Fotopoulou, Christina
    Gonzalez Martin, Antonio
    Lax, Sigurd
    Lorusso, Domenica
    Marth, Christian
    Morice, Philippe
    Nout, Remi A.
    O'Donnell, Dearbhaile
    Querleu, Denis
    Raspollini, Maria Rosaria
    Sehouli, Jalid
    Sturdza, Alina
    Taylor, Alexandra
    Westermann, Anneke
    Wimberger, Pauline
    Colombo, Nicoletta
    Planchamp, Francois
    Creutzberg, Carien L.
    [J]. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 (01) : 12 - 39
  • [10] Retrospective analysis of selective lymphadenectomy in apparent early-stage endometrial cancer
    Cragun, JM
    Havrilesky, LJ
    Calingaert, B
    Synan, I
    Secord, AA
    Soper, JT
    Clarke-Pearson, DL
    Berchuck, A
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 3668 - 3675